FDA Inspection
Novartis Pharma S.A.S. - Centre de BiotechnologieNovartis Pharma S.A.S. - Centre de Biotechnologie – FDA Inspection, Sep 12, 2017
Record Details
This FDA Inspection record concerns Novartis Pharma S.A.S. - Centre de Biotechnologie, with an inspection on September 12, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- September 12, 2017
- Product Type
- Drugs
View Company Profile
ID · 8615aa30-3785-4cab-af8d-bbcb1a2be973
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1026805
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Novartis Pharma S.A.S. - Centre de Biotechnologie
3| Date | Classification | Office | Project area |
|---|---|---|---|
| November 19, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 18, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 31, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Novartis Pharma S.A.S. - Centre de Biotechnologie
- FDA Inspection 1173120 - 2020-11-19
- FDA Inspection 878418 - 2014-03-18
- FDA Inspection 787415 - 2012-01-31
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.